— Know what they know.
Not Investment Advice

SRRK NASDAQ

Scholar Rock Holding Corporation
1W: -6.9% 1M: +0.8% 3M: -0.6% YTD: +11.5% 1Y: +51.3% 3Y: +475.6% 5Y: +70.9%
$48.13
+0.41 (+0.86%)
 
Weekly Expected Move ±4.5%
$45 $47 $49 $52 $54
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 49 · $5.8B mcap · 96M float · 1.55% daily turnover · Short 52% of daily vol

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
-$2M +14.4% ▲
Operating Income
-$385M -52.6% ▼
Net Income
-$378M -53.5% ▼
EPS (Diluted)
$-3.29 -33.2% ▼
EBITDA
-$369M -55.5% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$19M$33M$0$0$0
YoY Growth+22.2%+76.4%-100.0%+0.0%+0.0%
Cost of Revenue$108M$123M$3M$2M$2M
Gross Profit-$90M-$90M-$3M-$2M-$2M
Gross Margin-476.5%-270.7%
R&D Expenses$108M$124M$119M$183M$207M
SG&A Expenses$40M$43M$49M$68M$176M
Operating Expenses$40M$45M$168M$250M$383M
Operating Income-$130M-$134M-$171M-$252M-$385M
Operating Margin-690.5%-404.8%
Interest Expense$0$0$0$7M$7M
Income Before Tax-$132M-$135M-$166M-$246M-$378M
Tax Expense$0$0$0$0$0
Net Income-$132M-$135M-$166M-$246M-$378M
Net Margin-700.5%-405.2%
EPS (Diluted)$-3.59$-2.21$-1.99$-2.47$-3.29
EBITDA-$127M-$129M-$163M-$238M-$369M
Shares Outstanding37M60M76M100M115M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms